NXS – Next Science

Date:


Next Science's objective is to commercialise its proprietary technology for the treatment of biofilm protected bacteria, primarily in the area of human health and with potential applications in animal health and industrial segments.

The Company's proprietary Xbio technology is a non-toxic technology with proven efficacy in eradicating biofilm and biofilm protected bacteria. Xbio has been validated by extensive clinical testing, multiple FDA clearances and more than 70,000 patient treatments…

Read more



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

TD1 – TALI Digital

Avexa.com.au Bought into this stock at 30c a couple...

Winners and losers from opening day of NBA free agency

NBA free agency began on Monday with a...